Compare SRZN & ACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRZN | ACH |
|---|---|---|
| Founded | 2015 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.3M | 173.3M |
| IPO Year | N/A | N/A |
| Metric | SRZN | ACH |
|---|---|---|
| Price | $27.80 | $2.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $38.00 | $3.38 |
| AVG Volume (30 Days) | 67.1K | ★ 754.3K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | $4.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.11 | $1.84 |
| 52 Week High | $29.99 | $2.80 |
| Indicator | SRZN | ACH |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 66.99 |
| Support Level | $23.56 | $1.93 |
| Resistance Level | $28.78 | $2.80 |
| Average True Range (ATR) | 1.91 | 0.17 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 66.67 | 98.68 |
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Accendra Health Inc is a world-wide healthcare solutions company providing essential products, services and technology solutions that support care delivery in hospitals, health systems and research centers around the world.